Strategies for the isolation and purification of retroviral vectors for gene therapy

被引：0
|
作者：
Biochemical Recovery Group, School of Chemical Engineering, University of Birmingham, Birmingham BIS 2TT, United Kingdom [1 ]
不详 [2 ]
不详 [3 ]
不详 [4 ]
机构：
来源：
BIOSEPARATION | / 4卷 / 211-228期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
88
引用
收藏
相关论文
共 50 条
  • [1] Strategies for the isolation and purification of retroviral vectors for gene therapy
    Braas, G
    Searle, PF
    Slater, NKH
    Lyddiatt, A
    BIOSEPARATION, 1996, 6 (04) : 211 - 228
  • [2] Scateabte purification process for gene therapy retroviral vectors
    Rodrigues, Teresa
    Carvalho, Andreia
    Carmo, Marlene
    Carrondo, Manuel J. T.
    Alves, Paula M.
    Cruz, Pedro E.
    JOURNAL OF GENE MEDICINE, 2007, 9 (04): : 233 - 243
  • [3] Retroviral vectors for gene therapy
    Guntaka, Ramareddy V.
    Swamynathan, S.K.
    Indian Journal of Experimental Biology, 1998, 36 (06): : 539 - 545
  • [4] Retroviral vectors for gene therapy
    Maier, Patrick
    von Kalle, Christof
    Laufs, Stephanie
    FUTURE MICROBIOLOGY, 2010, 5 (10) : 1507 - 1523
  • [5] Retroviral vectors for human gene therapy
    Ferrari, G
    MINERVA BIOTECNOLOGICA, 1997, 9 (03) : 108 - 116
  • [6] Retroviral vectors for gene therapy.
    Prassolov, VS
    Ivanov, DS
    VOPROSY MEDITSINSKOI KHIMII, 2000, 46 (03): : 207 - 225
  • [7] Retroviral vectors and gene therapy: An update
    Maurya, S. K.
    Srivastava, Sushant
    Joshi, R. K.
    INDIAN JOURNAL OF BIOTECHNOLOGY, 2009, 8 (04): : 349 - 357
  • [8] Retroviral vectors for cancer gene therapy
    Collins, M
    THERAPEUTIC VACCINATION STRATEGIES, 2000, 30 : 99 - 104
  • [9] TARGETING OF RETROVIRAL VECTORS FOR GENE-THERAPY
    SALMONS, B
    GUNZBURG, WH
    HUMAN GENE THERAPY, 1993, 4 (02) : 129 - 141
  • [10] Replicative retroviral vectors for cancer gene therapy
    Solly, SK
    Trajcevski, S
    Frisén, C
    Holzer, GW
    Nelson, E
    Clerc, A
    Abordo-Adesida, E
    Castro, M
    Lowenstein, P
    Klatzmann, D
    CANCER GENE THERAPY, 2003, 10 (01) : 30 - 39
12345